5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Soft Tissue Repair Market is segmented by Product (Tissue Fixation Devices, Tissue Matrix, and Other Products), Application, and Geography.
Fastest Growing Market:
The soft tissue repair market has been observing a steady growth, with more requirement in increasing number of sports-related injuries. As per the Center for Disease Prevention and Control, participation in organized sports is getting accelerated, and about 30 million children and adolescents participate in youth sports in the United States annually, and more than 2.5 million children and teens are treated for sports-related injuries in the emergency department every year. The most common injuries are sprains and strains. According to the National Athletic Trainers' Association Position Statement: Preventing and Managing Sport-Related Dental and Oral Injuries by Gould TE et al., in 2016, orofacial injuries represented a small percentage of all sport-related injuries, and the financial burden associated with these injuries can exceed USD 15, 000 over adult life. With the growing inclination toward sports in Asia-Pacific region, sports-related injuries have generated a high scope of growth in the soft tissue repair market. According to the research article, ‘Football injuries at Asian tournaments’ by Yoon et al., there is a higher injury rate at the national team level of soccer in Asia, as compared to Europe. This increasing trend of sports-related injury has been acting as one of the key growth drivers of the soft tissue repair market.
Soft tissue repair device is used to treat soft tissue injury, which is characterized by damage to muscles, ligaments, or tendons throughout the body. It often occurs during sports and exercise activities, but sometimes simple daily activities can also cause soft tissue injury. The scope of the report considers the products and their applications in various injuries, as mentioned below.
|Pelvic and Vaginal Prolapse Repair|
Report scope can be customized per your requirements. Click here.
The source of biological grafts are human, bovine, and porcine tissues, which have been decellularized to leave a collagen matrix. Biological mesh is used to overcome the complications of synthetic meshes and to provide mechanical support, in order to create highly organized collagen network to establish new vascular access to the hernia site. Biologic grafts represent a major advancement in complex hernia repair when synthetic mesh is inappropriate. The biological mesh is estimated to witness lower CAGR for being more expensive than synthetic mesh. Although biological meshes show great promise in case of hernia repair, however, currently, surgeons prefer synthetic meshes more than biological mesh as connective tissue formed by these materials is only relatively lower. The biological mesh segment is expected to face challenges, due to risk of long-term recurrence and relatively high cost of this mesh.
To understand key trends, Download Sample Report
North America is expected to dominate the overall market, throughout the forecast period. In North America region, the United States holds the largest market share and this is due to the due to highly advanced medical care facilities and consistently high healthcare expenditure which would help the growth of the soft tissue repair market in the country.
To understand geography trends, Download Sample Report.
The Soft Tissue Repair market is competitive and consists of a major players and small players. In terms of market share, these major players currently dominate the market. Some of the major players of the market are Arthrex, Inc., Baxter Healthcare Corporation, Boston Scientific Corporation, Medtronic PLC, Stryker Corporation are among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Sports Related Injury
4.2.2 Rising Number of Trauma Cases
4.2.3 Growing Geriatric Population
4.3 Market Restraints
4.3.1 High Cost of Surgical Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Tissue Fixation Devices
18.104.22.168 Suture Anchor
22.214.171.124 Interference Screws
126.96.36.199 Other Devices
5.1.2 Tissue Matrix
188.8.131.52 Synthetic Mesh
184.108.40.206 Biologic Mesh
5.1.3 Other Products
5.2 By Application
5.2.2 Dental Repair
5.2.3 Hernia Repair
5.2.4 Breast Reconstruction
5.2.5 Skin Repair
5.2.6 Pelvic and Vaginal Prolapse Repair
5.3.1 North America
220.127.116.11 Rest of Europe
5.3.3 Asia Pacific
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.3.4 Middle East and Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East and Africa
5.3.5 South America
184.108.40.206 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Arthrex, Inc.
6.1.2 Baxter Healthcare Corporation
6.1.3 Boston Scientific Corporation
6.1.4 CryoLife, Inc.
6.1.5 Integra LifeSciences Corporation
6.1.6 Johnson & Johnson
6.1.7 Medtronic PLC
6.1.8 Becton Dickinson and Company (C.R. Bard, Inc.)
6.1.9 Smith & Nephew PLC
6.1.10 Stryker Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments